Navigation Links
NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and Care
Date:7/23/2009

PRINCETON, N.J., July 23 /PRNewswire/ -- The National Changing Diabetes((R)) Program (NCDP), a program of Novo Nordisk, and several member associations today urged President Obama and members of Congress to make the prevention, detection and treatment of diabetes, one of the nation's most pervasive and costly diseases, a priority in reforming the U.S. healthcare system.

In an open letter to the President and lawmakers, NCDP said a national response to diabetes is required in order to transform health care and begin to ease the economic and personal burden of the disease, which is growing at an alarming rate. Today more than one in four Americans have diabetes or pre-diabetes, and these two conditions are estimated to have cost the U.S. $218 billion in 2007 in medical care and lost productivity, according to a recent study.

Joining the NCDP in reaching out to lawmakers are the American Diabetes Association, the American College of Physicians and VSP.

"We applaud the effort to reorient our health care system to focus more on the prevention of disease, and nowhere is the need greater than with diabetes," said Dana Haza, senior director of NCDP, an initiative created by Novo Nordisk to drive health systems change at the national and local level. "Not only does diabetes frequently result in devastating and costly complications, but diabetes also significantly increases the risk of heart disease, stroke, blindness, kidney disease, amputations and depression. So tackling diabetes early will make a huge impact on our nation's overall health care system."

Type 2 diabetes, the most prevalent form of the disease, can often be delayed or prevented. Data show that the risk of type 2 diabetes can be prevented or at least significantly delayed by losing even a modest amount of weight through diet and regular exercise. Further, other studies have shown that the onset and progression of eye, kidney and nerve complications resulting from diabetes can be delayed by keeping blood glucose levels as close to normal as possible.

"We know that these lifestyle modifications and interventions work. Now we need to reform the health care system to promote them," Haza said.

The NCDP is calling on lawmakers to ensure diabetes is a top priority for health reform, including all new or expanded initiatives in public programs such as Medicare, Medicaid and CHIP. The organization said diabetes needs to be specifically identified as a priority condition for:

  • Patient-centered care models
  • Chronic care management programs
  • Health information technology programs
  • Programs to reduce racial and ethnic disparities in health care
  • Prevention and health promotion initiatives
  • Quality improvement initiatives
  • Quality-based incentives
  • Medicare and Medicaid demonstrations of new care models and delivery systems

"We are facing a unique opportunity to profoundly change health care in America and improve the lives of countless people," Haza said. "Changing diabetes is essential to health care reform."

About the National Changing Diabetes((R)) Program

The National Changing Diabetes((R)) Program (NCDP) is a multi-faceted initiative that brings together leaders in diabetes and policy to improve the lives of people with diabetes. NCDP strives to create change in the U.S. health care system to provide dramatic improvement in the prevention and care of diabetes. Launched in 2005, NCDP is a program of Novo Nordisk. For more information, please visit www.ncdp.com.

About Novo Nordisk

Novo Nordisk is a healthcare company with an 86-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. With headquarters in Denmark, Novo Nordisk employs more than 27,550 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For global information, visit novonordisk.com; for United States information, visit novonordisk-us.com.


'/>"/>
SOURCE The National Changing Diabetes Program
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT Highlights the Burgeoning Demographics of Orthopaedics and the Continuing Health of the Industry
2. Rising Medical Solutions, Inc. Launches Unified Healthcare Portal for Payers, Patients and Providers
3. Introducing Healthspottr: The New Voice of Healthcare Innovation
4. Survey Reveals Women Arent Doing All They Can to Support Breast Health
5. Resurrection Health Care Primary Stroke Care Programs Awarded Accreditation from Joint Commission
6. Gentiva(R) Health Services Signs Agreement to Acquire Home Health Agency with Offices in Mississippi and Alabama
7. Black Activist Speaks Out Against Race Preferences in Health Care Bill
8. President Obamas Health Care Plan: Too Big, Too Expensive, Too Rushed
9. Michigan State Medical Society Weighs in on Proposed Federal Health Care Reform Legislation
10. Majority of Public Maintains Support for Addressing Health Care Reform Now
11. Team24 News Article - New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
Breaking Medicine Technology: